Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.07
-0.72 (-0.35%)
AAPL  262.33
-2.02 (-0.76%)
AMD  200.38
+0.26 (0.13%)
BAC  52.52
-0.84 (-1.56%)
GOOG  304.64
+0.70 (0.23%)
META  644.32
+1.10 (0.17%)
MSFT  398.14
-1.46 (-0.37%)
NVDA  186.14
-1.84 (-0.98%)
ORCL  157.60
+1.44 (0.92%)
TSLA  410.29
-1.03 (-0.25%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.